Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-α expression

Digestive Diseases and Sciences

Volumn 55, Issue 10, 2010, Pages 2797-2804

  Takagi, Tomohisa ^a   Naito, Yuji ^a   Mizushima, Katsura ^a   Akagiri, Satomi ^a   Suzuki, Takahiro ^a   Hirata, Ikuhiro ^a   Omatsu, Tatsushi ^a   Handa, Osamu ^a   Kokura, Satoshi ^a   Ichikawa, Hiroshi ^a   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

2,4,6 trinitrobenzine sulfonic acid (TNBS) colitis; Carbon monoxide (CO); Inflammatory bowel disease (IBD); Tumor necrosis factor (TNF)

Indexed keywords

CARBON MONOXIDE; CD3 ANTIBODY; MONOCLONAL ANTIBODY CD28; MYELOPEROXIDASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA; ANTIBODY; ANTIINFLAMMATORY AGENT; CD28 ANTIGEN; CD3 ANTIGEN; MESSENGER RNA; PEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL STIMULATION; COLITIS; COLON INJURY; COLON MUCOSA; COLON ULCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DESCENDING COLON; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; SUPERNATANT; THERAPY EFFECT; ANIMAL; C57BL MOUSE; CELL CULTURE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DISEASE MODEL; DOSE RESPONSE; GENETICS; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PHYSIOLOGY;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES; ANTIGENS, CD28; ANTIGENS, CD3; CARBON MONOXIDE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; COLITIS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; PEROXIDASE; RNA, MESSENGER; SPLEEN; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77957913463     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1112-x     Document Type: Article

References (44)

1. Cobrin GM, Abreu MT. Defects in mucosal immunity leading to Crohn's disease. Immunol Rev. 2005;206:277-295.
2. Xavier RJ, Podolsky DK. Unravelling the pathogenesis of inflammatory bowel disease. Nature. 2007;448:427-434.
3. Rutgeerts P, Vermeire S, Van Assche G. Biological therapies for inflammatory bowel diseases. Gastroenterology. 2009;136: 1182-1197.
4. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet. 2007;369:1641-1657.
5. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37: 517-554.
6. Naito Y, Takagi T, Yoshikawa T. Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease. Aliment Pharmacol Ther. 2004;20(Suppl 1):177-184.
7. Sassa S. Biological implications of heme metabolism. J Clin Biochem Nutr. 2006;38:138-155.
8. Alcaraz MJ, Fernandez P, Guillen MI. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des. 2003;9:2541-2551.
9. Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8: 240-246.
10. Morse D, Choi AM. Heme oxygenase-1: from bench to bedside. Am J Respir Crit Care Med. 2005;172:660-670.
11. Nakao A, Kaczorowski DJ, Sugimoto R, Billiar TR, McCurry KR. Application of heme oxygenase-1, carbon monoxide and biliverdin for the prevention of intestinal ischemia/reperfusion injury. J Clin Biochem Nutr. 2008;42:78-88.
12. Takagi T, Naito Y, Mizushima K, et al. Increased intestinal expression of heme oxygenase-1 and its localization in patients with ulcerative colitis. J Gastroenterol Hepatol. 2008;23(Suppl 2):S229-S233.
13. Paul G, Bataille F, Obermeier F, et al. Analysis of intestinal haem-oxygenase-1 (ho-1) in clinical and experimental colitis. Clin Exp Immunol. 2005;140:547-555.
14. Wang WP, Guo X, Koo MW, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2001;281: G586-G594.
15. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol. 1999;276:L688-L694.
16. Kaizu T, Nakao A, Tsung A, et al. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery. 2005;138:229-235.
17. Nakao A, Kimizuka K, Stolz DB, et al. Carbon monoxide inhalation protects rat intestinal grafts from ischemia/reperfusion injury. Am J Pathol. 2003;163:1587-1598.
18. Nakao A, Toyokawa H, Abe M, et al. Heart allograft protection with low-dose carbon monoxide inhalation: effects on inflammatory mediators and alloreactive t-cell responses. Transplantation. 2006;81:220-230.
19. Neto JS, Nakao A, Kimizuka K, et al. Protection of transplantinduced renal ischemia-reperfusion injury with carbon monoxide. Am J Physiol Renal Physiol. 2004;287:F979-F989.
20. Takagi T, Naito Y, Inoue M, et al. Inhalation of carbon monoxide ameliorates collagen-induced arthritis in mice and regulates the articular expression of il-1beta and mcp-1. Inflammation. 2009;32:83-88.
21. Tsui TY, Obed A, Siu YT, et al. Carbon monoxide inhalation rescues mice from fulminant hepatitis through improving hepatic energy metabolism. Shock. 2007;27:165-171.
22. Hegazi RA, Rao KN, Mayle A, Sepulveda AR, Otterbein LE, Plevy SE. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J Exp Med. 2005;202:1703-1713.
23. Zuckerbraun BS, Otterbein LE, Boyle P, et al. Carbon monoxide protects against the development of experimental necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2005;289:G607-G613.
24. Kaizu T, Ikeda A, Nakao A, et al. Protection of transplantinduced hepatic ischemia/reperfusion injury with carbon monoxide via mek/erk1/2 pathway downregulation. Am J Physiol Gastrointest Liver Physiol. 2008;294:G236-G244.
25. McCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut. 1999;45:864-873.
26. Sugimoto N, Rui T, Yang M, et al. Points of control exerted along the macrophage-endothelial cell-polymorphonuclear neutrophil axis by pecam-1 in the innate immune response of acute colonic inflammation. J Immunol. 2008;181:2145-2154.
27. Otterbein LE, Bach FH, Alam J, et al. Carbon monoxide has antiinflammatory effects involving the mitogen-activated protein kinase pathway. Nat Med. 2000;6:422-428.
28. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351-358.
29. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol. 1986;251:G567-G574.
30. Niki E, Komuro E. Inhibition of peroxidation of membranes. Basic Life Sci. 1988;49:561-566.
31. Niki E, Noguchi N, Gotoh N. Dynamics of lipid peroxidation and its inhibition by antioxidants. Biochem Soc Trans. 1993;21: 313-317.
32. Isozaki Y, Yoshida N, Kuroda M, et al. Effect of a novel watersoluble vitamin E derivative as a cure for TNBS-induced colitis in rats. Int J Mol Med. 2006;17:497-502.
33. Segui J, Gironella M, Sans M, et al. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine. J Leukoc Biol. 2004;76:537-544.
34. Sener G, Aksoy H, Sehirli O, et al. Erdosteine prevents colonic inflammation through its antioxidant and free radical scavenging activities. Dig Dis Sci. 2007;52:2122-2132.
35. Naito Y, Takagi T, Yoshikawa T. Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease. J Gastroenterol. 2007;42:787-798.
36. Naito Y, Takagi T, Yoshikawa T. Neutrophil-dependent oxidative stress in ulcerative colitis. J Clin Biochem Nutr. 2007;41: 18-26.
37. Freitas A, Alves-Filho JC, Secco DD, et al. Heme oxygenase/ carbon monoxide-biliverdin pathway down regulates neutrophil rolling, adhesion and migration in acute inflammation. Br J Pharmacol. 2006;149:345-354.
38. Ghosh S, Wilson MR, Choudhury S, et al. Effects of inhaled carbon monoxide on acute lung injury in mice. Am J Physiol Lung Cell Mol Physiol. 2005;288:L1003-L1009.
39. Shiohira S, Yoshida T, Shirota S, Tsuchiya K, Nitta K. Protective effect of carbon monoxide donor compounds in endotoxininduced acute renal failure. Am J Nephrol. 2007;27:441-446.
40. Lee SS, Gao W, Mazzola S, et al. Heme oxygenase-1, carbon monoxide, and bilirubin induce tolerance in recipients toward islet allografts by modulating T regulatory cells. Faseb J. 2007;21:3450-3457.
41. Brusko TM, Wasserfall CH, Agarwal A, Kapturczak MH, Atkinson MA. An integral role for heme oxygenase-1 and carbon monoxide in maintaining peripheral tolerance by cd4 ? cd25 ? regulatory T cells. J Immunol. 2005;174:5181-5186.
42. Hu CM, Lin HH, Chiang MT, Chang PF, Chau LY. Systemic expression of heme oxygenase-1 ameliorates type 1 diabetes in nod mice. Diabetes. 2007;56:1240-1247.
43. McDaid J, Yamashita K, Chora A, et al. Heme oxygenase-1 modulates the allo-immune response by promoting activationinduced cell death of T cells. Faseb J. 2005;19:458-460.
44. Pae HO, Oh GS, Choi BM, et al. Carbon monoxide produced by heme oxygenase-1 suppresses T cell proliferation via inhibition of IL-2 production. J Immunol. 2004;172:4744-4751.